Combination of the bioreductive drug tirapazamine with the chemotherapeutic prodrug cyclophosphamide for P450/P450-reductase-based cancer gene therapy.
about
Transcriptional Targeting in Cancer Gene TherapyProdrugs for Gene-Directed Enzyme-Prodrug Therapy (Suicide Gene Therapy)Hypoxia and oxidative stress. Tumour hypoxia--therapeutic considerationsSynthesis and characterization of a hypoxia-sensitive MRI probeGene therapy and targeted toxins for glioma.Conditionally replicating adenoviruses for cancer treatment.Drug testing and flow cytometry analysis on a large number of uniform sized tumor spheroids using a microfluidic deviceEnhancement of intratumoral cyclophosphamide pharmacokinetics and antitumor activity in a P450 2B11-based cancer gene therapy model.Potentiation of methoxymorpholinyl doxorubicin antitumor activity by P450 3A4 gene transfer.Tirapazamine-doxorubicin interaction referring to heart oxidative stress and Ca²⁺ balance protein levels.Gene therapy and targeted toxins for glioma
P2860
Q24791038-F5B14BCD-79EE-4E93-9A08-4B1040B4D5E3Q24792836-6E8F6965-76D5-4AE0-B2F8-EBFA1E6670F9Q24801771-94687023-141B-45CB-9D73-086100DC99C3Q34319457-E8D67433-259B-4FA8-96AB-2D4DCD03A3B0Q35118933-F1074A06-A588-4736-B43A-2D1D78CE50D9Q35967313-46DD8BF3-1349-4B9F-824E-FF5E4528A301Q36579534-4C8CC287-09D9-4648-B265-97C79EF9F77AQ37037051-1DB54BE1-BA7B-40CC-9842-00C829DE8B16Q39916257-CF1A7FB0-A3F8-4215-B786-7C2CE98DA8B9Q41991319-DFD9AC01-D623-4FB2-8832-F393EBBF6297Q57006162-2AA58EE5-CACB-4DCB-ADA1-13ECCBD10FFA
P2860
Combination of the bioreductive drug tirapazamine with the chemotherapeutic prodrug cyclophosphamide for P450/P450-reductase-based cancer gene therapy.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Combination of the bioreductiv ...... ase-based cancer gene therapy.
@ast
Combination of the bioreductiv ...... ase-based cancer gene therapy.
@en
type
label
Combination of the bioreductiv ...... ase-based cancer gene therapy.
@ast
Combination of the bioreductiv ...... ase-based cancer gene therapy.
@en
prefLabel
Combination of the bioreductiv ...... ase-based cancer gene therapy.
@ast
Combination of the bioreductiv ...... ase-based cancer gene therapy.
@en
P1433
P1476
Combination of the bioreductiv ...... tase-based cancer gene therapy
@en
P2093
Y Jounaidi
P304
P407
P577
2000-07-01T00:00:00Z